Investigation of the Aural Symptoms and Dizziness in Patients With Temporomandibular Joint Disorders

July 11, 2022 updated by: Merve Damla Korkmaz, Kanuni Sultan Suleyman Training and Research Hospital

120 male and female patients aged between 18-65 years who apply to the outpatient clinic and diagnosed with TMD will be included in the study. Patients will be divided into 3 groups as Muscle Disorders (Group 1), Temporomandibular Joint Disorders (Group 2) and degenerative joint diseas (osteoarthrosis) (Group 3) according to DC/TMD axis I diagnostic criteria.

maximum mouth opening, TMJ sound, pain levels, tinnitus, and dizziness are evaluated.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

120 male and female patients aged between 18-65 years who apply to the outpatient clinic and diagnosed with TMD will be included in the study. Patients will be divided into 3 groups as Muscle Disorders (Group 1), Temporomandibular Joint Disorders (Group 2) and degenerative joint diseas (osteoarthrosis) (Group 3) according to DC/TMD axis I diagnostic criteria.

Demographic data of all patients participating in the study will be obtained. Then, physical examination will reveal maximum mouth opening, right and left lateral movement, deflexion, deviation. Accompanying tinnitus, ear fullness and dizziness will be questioned.

All measurements, including maximum mouth opening, and physical examination will be performed with patients sitting upright in an anatomical position in a chair. All measurements will be performed by the same physical therapist with 7 years of experience in TMD.

In the measurement of maximum mouth opening, patients will be asked to open their mouths as wide as possible. The distance between the anterior incisors is measured with the help of a ruler suitable for millimeter measurement. Maximum mouth opening distance is a physical examination method frequently used to determine the motion and function of the jaw joint. Functional mouth opening is accepted as 35-40 mm (12).

For the evaluation of TMJ sound, the TMJ is palpated with the thumb and middle fingers and the sound heard when opening and closing the mesh is noted.

Pain levels are measured using a 10-point visual analog scale (VAS). The presence of bruxism is determined on physical examination based on the presence of abnormal tooth wear, tooth marks in the buccal region, tooth marks on the tongue, and hypertrophy of the masseter muscle.

The sense of fullness in the ear, tinnitus, and dizzyness, which the patients reported themselves, is questioned. The relationship between having TMD, clinical characteristics and dizziness will be evaluated.

Study Type

Observational

Enrollment (Actual)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Kucukcekmece
      • Istanbul, Kucukcekmece, Turkey, 34303
        • Kanuni Sultan Suleyman Training and Research Hospital
      • Istanbul, Kucukcekmece, Turkey, 34307
        • Kanuni Sultan Suleyman Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

participants aged 18-65 years with TMD

Description

Inclusion Criteria:

  • being 18-65 years of age
  • diagnosed with TMD

Exclusion Criteria:

  • Lack of cognitive ability to understand test instructions, illliteracy, aphasia, presence of a known psychiatric illness
  • Patients under the age of 18 and over the age of 65
  • Having another systemic disease that will cause TMD (cancer, rheumatological diseases)
  • Presence of disease that will increase a anotherural symptoms or cause d d (presence of disease of vertigo, history of vertigo)
  • Presence of a history of cervical pain, cervical spondylosis, cervical disc herniation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
maximum mouth opening
Time Frame: 1 day
maximum mouth opening
1 day
right and left lateral movement, deflexion, and deviation
Time Frame: 1 day
right and left lateral movement, deflexion, and deviation
1 day
TMJ sound
Time Frame: 1 day
the TMJis palpated with the thumb and middle fingers and the sound heard when opening and closing the mesh was noted.
1 day
visual analog scale
Time Frame: 1 day
It is use for evaluate the pain intensity.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
bruxism
Time Frame: 1 day
it is determined on physical examination based on the presence of abnormal tooth wear, tooth marks in the buccal region, tooth marks on the tongue, and hypertrophy of the masseter muscle.
1 day
the presence of bruxism, tinnitus and dizzeness
Time Frame: 1 day
the presence of bruxism, tinnitus and dizzeness
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Collaborators

Kirsehir Ahi Evran Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 27, 2022

Primary Completion (Actual)

June 1, 2022

Study Completion (Actual)

June 15, 2022

Study Registration Dates

First Submitted

May 28, 2022

First Submitted That Met QC Criteria

May 28, 2022

First Posted (Actual)

June 2, 2022

Study Record Updates

Last Update Posted (Actual)

July 13, 2022

Last Update Submitted That Met QC Criteria

July 11, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KAEK/2022.03.55

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dizziness

Clinical Trials on temporomandbular joint disorders

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe